Philips Respironics agrees to pay $1.1 billion settlement after CPAP machine recall
Philips also concluded an agreement with insurers to pay Philips EUR 540 million to cover Respironics recall-related product liability claims
Philips also concluded an agreement with insurers to pay Philips EUR 540 million to cover Respironics recall-related product liability claims
Keimed is a leading wholesale pharma distribution with industry leading operating metrics
New solvent-free micronization technology expanded at the Darmstadt site in Germany
The campaign marks an important milestone in its journey within the pharmaceutical manufacturing industry
Longest survival follow-up ever reported for immunotherapy treatment in this setting
The Gold Medal distinction places the company in the top 5% of all organizations assessed within EcoVadis's rigorous framework globally
IgAN is a heterogeneous, progressive, rare kidney disease and is a major cause of chronic kidney disease worldwide
Aims to become a leading global partner for botanical extracts and natural actives in the beauty and personal care market
The company will respond to the Warning Letter within the stipulated timelines
Subscribe To Our Newsletter & Stay Updated